Safety and Efficacy of Mesenchymal Stromal Cells (Amimestrocel ) in Diabetic Kidney Disease

Clinical trial NCT06969807 · RECRUITING

Trial details

NCT number: NCT06969807
Sponsor: Chinese PLA General Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetic Kidney Disease (DKD)

Start date: 2025-06-09
Primary completion: 2026-08-15
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.